Cost-effectiveness of routine and group programs for treatment of obese children

Marja Kalavainen1, Senja Karjalainen, Janne Martikainen

  • 1Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland. marja.kalavainen@kuh.fi

Insights

Family-based group treatment for childhood obesity is more expensive than routine counseling. While more effective, the higher costs, primarily from salaries, need consideration for resource allocation.

Area of Science:

  • Health Economics
  • Pediatric Obesity Treatment
  • Intervention Studies

Background:

  • Cost-effectiveness analysis is crucial for optimizing healthcare resource allocation.
  • Obese children require effective interventions, with group treatment previously showing higher efficacy.
  • This study compares the cost-effectiveness of group versus routine counseling for pediatric obesity.

Purpose of the Study:

  • To compare the cost-effectiveness of family-based group treatment versus routine counseling for obese children.
  • To determine the incremental cost-effectiveness ratio (ICER) for both interventions.

Main Methods:

  • A prospective 6-month intervention study comparing family-based group treatment with routine counseling.
  • Outcome measures included changes in weight for height and body mass index standard deviation scores (BMI-SDS).
  • Cost-effectiveness was analyzed from the service provider's perspective, calculating ICERs.

Main Results:

  • Group treatment incurred higher costs per unit of weight-for-height decrease and BMI-SDS decrease compared to routine counseling.
  • Incremental cost-effectiveness ratios were €53 per 1% weight-for-height decrease and €266-€275 per 0.1 BMI-SDS decrease.
  • Higher costs for group treatment were observed both at the end of the intervention and at 6-month follow-up.

Conclusions:

  • Family-based group treatment for childhood obesity is more costly than individual routine counseling.
  • Salaries constitute the majority of the total costs associated with the group treatment program.
  • The findings highlight the trade-off between effectiveness and cost in pediatric obesity interventions.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...